பயன்படுத்தப்பட்டது மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பயன்படுத்தப்பட்டது மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பயன்படுத்தப்பட்டது மருந்து Today - Breaking & Trending Today

ISU receives $1.48M grant to address rural health disparities


By Local News | MyWabashValley.com
May 25, 2021 | 4:10 PM
TERRE HAUTE, Ind. (WTWO/WAWV) Indiana State University has received a grant of more than $1.48 million from the federal Health Resources and Services Administration to support primary care physician assistant training for rural and medically underserved areas of Indiana. 
The grant will fund a five-year project called Preparing Physician Assistants for Rural Practice: Sycamore Physician Assistant Rural Care Program (SPARC). The grant project is the result of collaboration between ISU’s Office of Sponsored Programs, the Physician Assistant Studies program, and health professional programs including physical therapy, nursing, social work. Liz Metzger of Sponsored Programs and Nicole Heck of Physician Assistant Studies have been instrumental in securing the highly competitive federal grant. ....

United States , Indiana State University , Terre Haute , Doug Stevens , Caroline Mallory , Liz Metzger , John Pommier , Office Of Sponsored Programs , Physician Assistant Program , Dean Of The College Health , Health Resources , Human Services , Department Of Applied Medicine , Services Administration , Sycamore Physician Assistant Rural Care Program , Preparing Physician Assistants , Rural Practice , Sponsored Programs , Physician Assistant Studies , Nicole Heck , Applied Medicine , Assistant Professor , ஒன்றுபட்டது மாநிலங்களில் , இந்தியானா நிலை பல்கலைக்கழகம் , டெர்ரே ஹாட் , டக் ஸ்டீவன்ஸ் ,

University of Alberta: Researcher uses nanomedicine to improve effectiveness and safety of chemotherapy


Share
Afsaneh Lavasanifar is using nanotechnology to develop precise ways of delivering anti-cancer drugs to tumours, which could improve outcomes for patients while reducing side-effects of treatment. (Photo: Richard Siemens; taken pre-COVID-19)
A University of Alberta researcher is using nanotechnology to improve the effectiveness of chemotherapy treatments for cancer patients and reduce their side-effects.
Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of Chemical and Medical Engineering. Her lab develops precision health solutions through nanomedicine, finding ways to deliver drug-loaded nanoparticles to tumour sites.
“In nanomedicine, we are either working to improve the effectiveness of drugs that are already on the market or making new and better drugs by using (delivery) ‘vehicles’ that are in the nanometre-size range,” explained Lavasanifar ....

Afsaneh Lavasanifar , Richard Siemens , Frank Wuest , University Of Alberta , A University Of Alberta , Engineering Research Council Of Canada , Natural Sciences , Nanomedicines Innovation Network , Canadian Institutes Of Health Research , Alberta Cancer Foundation , Cancer Research Institute Of Northern Alberta , Department Of Chemical , Pharmaceutical Sciences , Cancer Research Institute , Northern Alberta , Meros Polymers , Engineering Research Council , Canadian Institutes , Health Research , Alberta Innovates , Nanomedicines Innovation , Applied Pharmaceutical , ரிச்சர்ட் ஸீமெந்ஸ் , வெளிப்படையான உெஸ்ட் , பல்கலைக்கழகம் ஆஃப் ஆல்பர்ட்டா , பொறியியல் ஆராய்ச்சி சபை ஆஃப் கனடா ,

Researcher uses nanomedicine to improve effectiveness and safety of chemotherapy


Date Time
Researcher uses nanomedicine to improve effectiveness and safety of chemotherapy
A University of Alberta researcher is using nanotechnology to improve the effectiveness of chemotherapy treatments for cancer patients and reduce their side-effects.
Afsaneh Lavasanifar is a professor in the University of Alberta’s Faculty of Pharmacy & Pharmaceutical Sciences and an adjunct professor in the Department of Chemical and Medical Engineering. Her lab develops precision health solutions through nanomedicine, finding ways to deliver drug-loaded nanoparticles to tumour sites.
“In nanomedicine, we are either working to improve the effectiveness of drugs that are already on the market or making new and better drugs by using (delivery) ‘vehicles’ that are in the nanometre-size range,” explained Lavasanifar. “These vehicles either make the drugs more effective or reduce their side-effects, or both.” ....

Afsaneh Lavasanifar , Frank Wuest , University Of Alberta , A University Of Alberta , Engineering Research Council Of Canada , Natural Sciences , Nanomedicines Innovation Network , Canadian Institutes Of Health Research , Alberta Cancer Foundation , Cancer Research Institute Of Northern Alberta , Department Of Chemical , Pharmaceutical Sciences , Cancer Research Institute , Northern Alberta , Meros Polymers , Engineering Research Council , Canadian Institutes , Health Research , Alberta Innovates , Nanomedicines Innovation , Applied Pharmaceutical , Research Council , Cancer Research , Clinical Trial , Heart Failure , Anti Cancer ,